Literature DB >> 14103041

[THE SEROLOGICAL DIAGNOSIS OF TOXOPLASMOSIS BY THE FLUORESCENT ANTIBODY METHOD (INDIRECT TECHNIC)].

J P GARIN, P AMBROISE-THOMAS.   

Abstract

Keywords:  FLUORESCENT ANTIBODY TECHNIC; TOXOPLASMOSIS

Mesh：

Year:  1963        PMID： 14103041

Source DB:  PubMed          Journal:  Presse Med        ISSN： 0032-7867            Impact factor:   1.228


× No keyword cloud information.
  6 in total

1.  [Serodiagnosis of toxoplasmosis: a comparative multicenter study of a standard scale through various actual tests and expression of the results in international units. Groupe de travail toxoplasmose du Contrôle national de qualité en parasotologie. Syndicat des fabricants de réactifs de laboratoire. Groupe de travail standardisation des tests sérologiques du Réseau européen de lutte contre la toxoplasmose congénitale].

Authors:  J C Petithory; P Ambroise-Thomas; J De Loye; H Pelloux; A Goullier-Fleuret; M Milgram; C Buffard; J P Garin
Journal:  Bull World Health Organ       Date:  1996       Impact factor: 9.408

2.  Bicentric evaluation of Access Toxo immunoglobulin M (IgM) and IgG assays and IMx toxo IgM and IgG assays and comparison with Platelia Toxo IgM and IgG assays.

Authors:  A Decoster; B Lecolier
Journal:  J Clin Microbiol       Date:  1996-07       Impact factor: 5.948

3.  Chronic lymphoglandular enlargement and toxoplasmosis in children.

Authors:  T Thomaidis; K Anastassea-Vlachou; C Mandalenaki-Lambrou; C Theodoridis; E Vrahnou
Journal:  Arch Dis Child       Date:  1977-05       Impact factor: 3.791

4.  [Serological diagnosis of toxoplasmosis using antigens produced in tissue culture].

Authors:  A Betz
Journal:  Bull World Health Organ       Date:  1968       Impact factor: 9.408

5.  Chronic toxoplasmosis with negative dye test?

Authors:  J S Robertson
Journal:  Postgrad Med J       Date:  1966-01       Impact factor: 2.401

6.  Incidence of toxoplasmosis in patients with cirrhosis.

Authors:  Sebnem Ustun; Umit Aksoy; Hande Dagci; Galip Ersoz
Journal:  World J Gastroenterol       Date:  2004-02-01       Impact factor: 5.742
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.